Nishitha Reddy

Nishitha Reddy

UNVERIFIED PROFILE

Are you Nishitha Reddy?   Register this Author

Register author
Nishitha Reddy

Nishitha Reddy

Publications by authors named "Nishitha Reddy"

Are you Nishitha Reddy?   Register this Author

86Publications

2286Reads

36Profile Views

Cardiovascular Toxicities Associated With Ibrutinib.

J Am Coll Cardiol 2019 Oct;74(13):1667-1678

Departments of Medicine and Pharmacology, Cardio-Oncology program, Vanderbilt University Medical Center, Nashville, Tennessee. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jacc.2019.07.056DOI Listing
October 2019

Durable responses in refractory autoimmune hemolytic anemia with alemtuzumab.

J Oncol Pharm Pract 2019 Apr 15;25(3):706-709. Epub 2018 Jan 15.

2 Department of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155217750463DOI Listing
April 2019

Age-dependent overall survival benefit of androgen deprivation therapy for metastatic prostate cancer.

J Oncol Pharm Pract 2019 Mar 16:1078155219835597. Epub 2019 Mar 16.

1 Division of Hematology and Oncology, Roger Williams Medical Center, Providence, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1078155219835597DOI Listing
March 2019

Treatment of newly diagnosed primary central nervous system lymphoma: current and emerging therapies.

Leuk Lymphoma 2019 01 9;60(1):6-18. Epub 2018 May 9.

a Division of Hematology/Oncology, Department of Medicine , Vanderbilt University Medical Center , Nashville , TN , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2018.1466296DOI Listing
January 2019

Early stage, bulky Hodgkin lymphoma patients have a favorable outcome when treated with or without consolidative radiotherapy: potential role of PET scan in treatment planning.

Br J Haematol 2017 11 13;179(4):674-676. Epub 2016 Jul 13.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14236DOI Listing
November 2017

Garcinia Cambogia, Diabetic Ketoacidosis, and Pancreatitis.

R I Med J (2013) 2017 Oct 2;100(10):48-50. Epub 2017 Oct 2.

Department of Pharmacy, University of Rhode Island College of Pharmacy, Kingston, RI.

View Article

Download full-text PDF

Source
October 2017

Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

J Clin Oncol 2017 Jul 5;35(20):2260-2267. Epub 2017 May 5.

Daniel J. Landsburg and Anthony R. Mato, University of Pennsylvania; James N. Gerson and Stefan K. Barta, Temple University, Philadelphia, PA; Marissa K. Falkiewicz, Robert Wood Johnson Medical School, New Brunswick; Christina Howlett, Tatyana Feldman, and Anthony R. Mato, Hackensack University Medical Center, Hackensack, NJ; Joseph Maly and Kristie A. Blum, Ohio State University, Columbus; Brian T. Hill, Cleveland Clinic, Cleveland, OH; Shaoying Li and L. Jeffrey Medeiros, MD Anderson Cancer Center, Houston, TX; Pallawi Torka and Francisco Hernandez-Ilizaliturri, Roswell Park Cancer Institute, Buffalo; Jennifer K. Lue and Jennifer E. Amengual, Columbia University, New York, NY; Nishitha M. Reddy, Vanderbilt University, Nashville, TN; Arun Singavi and Timothy S. Fenske, Medical College of Wisconsin, Milwaukee, WI; Julio C. Chavez, Moffitt Cancer Center, Tampa, FL; Jason B. Kaplan, Amir Behdad, and Adam M. Petrich, Northwestern University, Evanston; Adam M. Petrich, AbbVie, North Chicago; David J. Peace, University of Illinois, Urbana; Sunita Nathan, Rush University, Chicago, IL; Martin A. Bast and Julie M. Vose, University of Nebraska, Lincoln, NE; Adam J. Olszewski, Brown University, Providence, RI; Cristiana Costa and Frederick Lansigan, Dartmouth College, Hanover, NH; Oscar Calzada and Jonathon B. Cohen, Emory University, Atlanta, GA; Xavier Rivera and Daniel O. Persky, University of Arizona, Tucson, AZ; and Ryan D. Cassaday, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.2157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6366297PMC
July 2017

Management of Patients With Histologic Transformation.

Authors:
Nishitha M Reddy

Clin Lymphoma Myeloma Leuk 2017 07;17S:S100-S104

Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2017.02.020DOI Listing
July 2017

Beyond Anthracyclines: Preemptive Management of Cardiovascular Toxicity in the Era of Targeted Agents for Hematologic Malignancies.

Curr Hematol Malig Rep 2017 06;12(3):257-267

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, 3927 The Vanderbilt Clinic, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-017-0369-yDOI Listing
June 2017

Differences in outcome of patients with syncytial variant Hodgkin lymphoma compared with typical nodular sclerosis Hodgkin lymphoma.

Ther Adv Hematol 2017 Jan 30;8(1):13-20. Epub 2016 Oct 30.

Vanderbilt University, 3927 The Vanderbilt Clinic, 1301 Medical Center Drive, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620716676256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5167078PMC
January 2017

Beyond Epstein-Barr virus: genetic predisposition of natural killer T-cell lymphoma.

Lancet Oncol 2016 09 25;17(9):1176-7. Epub 2016 Jul 25.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(16)30205-4DOI Listing
September 2016

NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016.

J Natl Compr Canc Netw 2016 09;14(9):1067-79

From Memorial Sloan Kettering Cancer Center; Robert H. Lurie Comprehensive Cancer Center of Northwestern University; The University of Texas MD Anderson Cancer Center; Massachusetts General Hospital Cancer Center; Stanford Cancer Institute; UCSF Helen Diller Family Comprehensive Cancer Center; Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine; The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute; Fox Chase Cancer Center; Huntsman Cancer Institute at the University of Utah; Mayo Clinic Cancer Center; Roswell Park Cancer Institute; University of Michigan Comprehensive Cancer Center; Duke Cancer Institute; Consultant; Dana-Farber/Brigham and Women's Cancer Center; Fred & Pamela Buffett Cancer Center; City of Hope Comprehensive Cancer Center; Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance; University of Colorado Cancer Center; Vanderbilt-Ingram Cancer Center; UC San Diego Moores Cancer Center; Yale Cancer Center/Smilow Cancer Hospital; University of Alabama at Birmingham Comprehensive Cancer Center; Moffitt Cancer Center; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; St. Jude Children's Research Hospital/University of Tennessee Health Science Center; and National Comprehensive Cancer Network.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2016.0117DOI Listing
September 2016

Clinical Reasoning: A 52-year-old man with diplopia and ataxia.

Neurology 2016 09;87(13):e140-3

From the Departments of Neurology (M.J.B., S.P., P.M.), Medicine (Infectious Disease) and Health Policy (K.C.B.), and Medicine (Hematology and Oncology) (N.M.R.), Vanderbilt University Medical Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000003150DOI Listing
September 2016

CD30 expression and its correlation with MYC rearrangement in de novo diffuse large B-cell lymphoma.

Eur J Haematol 2016 Jul 1;97(1):39-47. Epub 2015 Oct 1.

Department of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12680DOI Listing
July 2016

High-grade B-cell Lymphoma With MYC Rearrangement and Without BCL2 and BCL6 Rearrangements Is Associated With High P53 Expression and a Poor Prognosis.

Am J Surg Pathol 2016 Feb;40(2):253-61

Departments of *Pathology‡Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN†Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000542DOI Listing
February 2016

Alternative intensive induction chemotherapeutic regimens in MYC expressing diffuse large B-cell lymphoma.

Leuk Lymphoma 2015 Mar 17;56(3):797-800. Epub 2014 Jul 17.

Division of Hematology and Oncology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2014.928937DOI Listing
March 2015

Increased serum tumor necrosis factor α levels in patients with lenalidomide-induced hypothyroidism.

Exp Hematol 2015 Feb 28;43(2):74-8. Epub 2014 Oct 28.

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2014.10.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002942PMC
February 2015

Stem cell transplantation in Hodgkin lymphoma.

Hematol Oncol Clin North Am 2014 Dec 26;28(6):1097-112. Epub 2014 Sep 26.

Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 298, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2014.08.011DOI Listing
December 2014

Profile of belinostat for the treatment of relapsed or refractory peripheral T-cell lymphoma.

Onco Targets Ther 2014 24;7:1971-7. Epub 2014 Oct 24.

Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/OTT.S59269DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216035PMC
November 2014

Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspective.

Ther Adv Hematol 2014 Oct;5(5):153-67

Vanderbilt University Medical Center, 3927 The Vanderbilt Clinic, Vanderbilt-Ingram Cancer Center, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620714547327DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199091PMC
October 2014

Outcomes of autologous or allogeneic stem cell transplantation for non-Hodgkin lymphoma.

Exp Hematol 2014 Jan 2;42(1):39-45. Epub 2013 Oct 2.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2013.09.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002948PMC
January 2014

Management of T-cell lymphomas: overcoming challenges and choosing the best treatment.

Semin Hematol 2014 Jan 19;51(1):1-4. Epub 2013 Nov 19.

Section of Hematology and Stem Cell Transplantation Division of Hematology/Oncology Department of Medicine Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2013.11.009DOI Listing
January 2014

Chemotherapeutic advancements in peripheral T-cell lymphoma.

Semin Hematol 2014 Jan 14;51(1):17-24. Epub 2013 Nov 14.

Division of Hematology and Oncology, Department of Medicine, Tufts University School of Medicine, Medford, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2013.11.006DOI Listing
January 2014

Novel therapeutic strategies for cutaneous T-cell lymphoma in advanced stages.

Semin Hematol 2014 Jan 14;51(1):35-41. Epub 2013 Nov 14.

Division of Hematology/Oncology(,) Vanderbilt-Ingram Cancer Center, Nashville, TN. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2013.11.004DOI Listing
January 2014

Phase I trial of the HSP90 inhibitor PF-04929113 (SNX5422) in adult patients with recurrent, refractory hematologic malignancies.

Clin Lymphoma Myeloma Leuk 2013 Aug 10;13(4):385-91. Epub 2013 Jun 10.

Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clml.2013.03.010DOI Listing
August 2013

Immune surveillance and lymphoid malignancy in immunocompromised host.

Am J Blood Res 2013 5;3(2):91-101. Epub 2013 May 5.

Division of Hematology and stem cell transplantation, Department of Medicine, Vanderbilt University Medical Center Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3649811PMC
May 2013

Brentuximab in the treatment of CD30-positive enteropathy-associated T-cell lymphoma.

J Natl Compr Canc Netw 2013 Feb;11(2):137-40; quiz 140

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2013.0021DOI Listing
February 2013

Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation.

Clin Lymphoma Myeloma Leuk 2012 Dec 14;12(6):406-11. Epub 2012 Sep 14.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S215226501200136
Publisher Site
http://dx.doi.org/10.1016/j.clml.2012.07.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845749PMC
December 2012

Advances and application of radioimmunotherapy in non-Hodgkin lymphoma.

Am J Blood Res 2012 22;2(2):86-97. Epub 2012 Apr 22.

Division of Hematology and Oncology, Department of Medicine, Vanderbilt University Medical Center Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3384399PMC
August 2012

Immunomodulatory nonablative conditioning regimen for B-cell lymphoid malignancies.

Exp Hematol 2012 Jun 21;40(6):431-5. Epub 2012 Jan 21.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2012.01.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067702PMC
June 2012

Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen.

Exp Hematol 2012 May 21;40(5):359-66. Epub 2012 Jan 21.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0301472X1200014
Publisher Site
http://dx.doi.org/10.1016/j.exphem.2012.01.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845757PMC
May 2012

Treatment options for transformed lymphoma: incorporating allogeneic stem cell transplantation in a multimodality approach.

Biol Blood Marrow Transplant 2011 Sep 11;17(9):1265-72. Epub 2011 May 11.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387911100208
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2011.05.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156833PMC
September 2011

High Prevalence of Obesity in Acute Promyelocytic Leukemia (APL): Implications for Differentiating Agents in APL and Metabolic Syndrome.

Ther Adv Hematol 2011 Jun;2(3):141-5

Department of Pathology, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620711408490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3573402PMC
June 2011

Strategies to prevent EBV reactivation and posttransplant lymphoproliferative disorders (PTLD) after allogeneic stem cell transplantation in high-risk patients.

Biol Blood Marrow Transplant 2011 May 21;17(5):591-7. Epub 2010 Aug 21.

Hematology and Stem Cell Transplantation Section, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232-5505, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S108387911000346
Publisher Site
http://dx.doi.org/10.1016/j.bbmt.2010.08.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763478PMC
May 2011

Hodgkin's lymphoma: Richter's transformation of chronic lymphocytic leukemia involving the liver.

J Clin Oncol 2010 Oct 16;28(29):e543-4. Epub 2010 Aug 16.

Vanderbilt University Medical Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.29.3050DOI Listing
October 2010

Primary bone lymphoma: a set of unique problems in management.

Leuk Lymphoma 2010 Jan;51(1):1-2

Department of Medicine, Division of Hematology-Oncology, Vanderbilt University Medical Center, Nashville, TN 37232-5505, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428190903470877DOI Listing
January 2010

Progressive multifocal leukoencephalopathy in a patient with follicular lymphoma treated with multiple courses of rituximab.

Leuk Lymphoma 2009 Mar;50(3):460-2

Division of Hematology and Oncology, Department of Medicine, Vanderbilt University, Nashville, TN 37232, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190802695827DOI Listing
March 2009

Toxicities and survival among octogenarians and nonagenarians with colorectal cancer treated with chemotherapy or concurrent chemoradiation therapy.

Clin Colorectal Cancer 2007 Jan;6(5):362-6

Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CCC.2007.n.005DOI Listing
January 2007

Immunomodulatory drug CC-5013 or CC-4047 and rituximab enhance antitumor activity in a severe combined immunodeficient mouse lymphoma model.

Clin Cancer Res 2005 Aug;11(16):5984-92

Department of Medicine , Roswell Park Cancer Institute Buffalo, New York 14263, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-0577DOI Listing
August 2005